FOXISAFE 5MG TABLET -Dapaglifozin 5 mg

Product Description

FOXISAFE 5MG TABLET Dapagliflozin 5 mgFOXISAFE 5MG TABLET contains Dapagliflozin 5 mg, a trusted SGLT2 inhibitor used to effectively manage Type 2 Diabetes Mellitus. This oral antidiabetic agent helps lower blood glucose levels by promoting urinary glucose excretion, offering a modern and targeted approach to glycemic control. Key Benefits: Helps control blood sugar levels in Type 2 Diabetes patients Supports cardiovascular and renal protection (as per current clinical guidelines) Oral, once-daily dosage for improved patient compliance Can be used as monotherapy or in combination with other antidiabetic agents Usage: FOXISAFE 5MG TABLET is prescribed for adult patients with Type 2 Diabetes Mellitus, especially those requiring an adjunct to diet and exercise. It is also indicated for patients with cardiovascular risk factors under physician supervision. Packaging & Supply: Strength: Dapagliflozin 5 mg Packing: Strip of 10 tablets Available for bulk orders and third-party manufacturing